| 1 - 3 | $21.95 ea. |
| 4 - 6 | $18.95 ea. |
| 7 - 12 | $18.45 ea. |
| 13+ | $17.95 ea. |
Dry macular degeneration is also known as atrophic macular degeneration, because of the atrophy of the retina. Dry macular degeneration symptoms include the formation of deposits below the retina that appear yellow or white (drusen) and atrophy or thinning of the pigment layer below the retina. Although dry macular degeneration is the more common form of age-related macular degeneration, approximately 10% of eyes progress to wet macular degeneration. This is also known as exudative macular degeneration. This form of macular degeneration results in the abnormal growth of new retinal blood vessels, known as neovascular membranes, that typically leak protein and bleed below the retina. When the leakage is located in the center of the retina, this can cause abrupt and severe vision loss. In 2001, the National Institutes of Health Age Related Eye Disease Study (AREDS) demonstrated that high dose nutritional supplements for macular degeneration slowed the progress of this disease. However, while this study proved that vision could be stabilized, it was unable to show vision improvement. Additionally, a small percentage (6%) of patients experienced urinary tract side and/or gastrointestinal side effects from the high Zinc levels. Since AREDS was first published in 2001, subsequent studies have shown more promising results! The Lutein Antioxidant Supplementation Trial (LAST) proved that when the antioxidants used the the Age Related Eye Disease Study were combined with 10 mg or more of Lutein, that vision improved in a significant number of patients! Finally, the issue of beta-carotene needed to be addressed for smokers and former habitual smokers. Although this precursor form of Vitamin A, which has excellent anti-oxidant properties is safe in non-smokers, two large population based studies demonstrated that beta-carotene increases the chances of acquiring lung cancer only in smokers or people with previous habitual smoking histories. VisiVite i-Defense Red Macular Degeneration Formula utilizes the important information from each of these groundbreaking studies. VisiVite i-Defense Red Formula is designed for smokers and former habitual smokers, and thus does not use beta-carotene. It then uses the remaining ingredients in the Age Related Eye Disease Study, and makes the following important therapeutic improvements: Zinc is reduced from 80 mg to 40 mg daily, to reduce
the urinary tract and gastrointestinal side effects experienced by 6% of
the patients in the study. As a result, VisiVite i-Defense Red
Formula has less than a 0.1% incidence of side effects that result in
having to discontinue the supplement. The National Eye Institute has
also seen the merit in this measure and will be doing the same in the
AREDS2 trial. 15 mg of FloraGLO brand Lutein, derived naturally
from Marigold Flowers, is added, based upon the results of the Lutein
Antioxidant Supplementation Trial which showed vision improvement in
people that had macular degeneration. This is the highest quality Lutein
available in any macular degeneration nutritional formula, and is 50%
more than the Lutein being used in the upcoming
AREDS2 trial. Unlike other manufactures that use synthetic dl-Alpha Vitamin E, VisiVite uses naturally derived d-Alpha Vitamin E. Natural Vitamin E is not only safer, it also has twice as much antioxidant power as Synthetic Vitamin E, because all of the molecules are in "right-handed" biologic orientation. Take one capsule twice daily. Capsules may be opened into food or drink
for patients that have difficulty swallowing. Are you looking for an even stronger
People with: • moderate vision loss due to dry macular degeneration • or who have lost vision in one eye due to wet macular degeneration and need to preserve vision in their remaining sighted eye • and who are smokers or former habitual smokers should use VisiVite i-Defense Green Formula. Click here for additional information. |
Directions: Take one capsule twice daily.

